Cargando…
Establishment and evaluation of glucose-modified nanocomposite liposomes for the treatment of cerebral malaria
Cerebral malaria (CM) is a life-threatening neurological complication caused by Plasmodium falciparum. About 627,000 patients died of malaria in 2020. Currently, artemisinin and its derivatives are the front-line drugs used for the treatment of cerebral malaria. However, they cannot target the brain...
Autores principales: | Tian, Ya, Zheng, Zhongyuan, Wang, Xi, Liu, Shuzhi, Gu, Liwei, Mu, Jing, Zheng, Xiaojun, Li, Yujie, Shen, Shuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258070/ https://www.ncbi.nlm.nih.gov/pubmed/35794597 http://dx.doi.org/10.1186/s12951-022-01493-8 |
Ejemplares similares
-
Development of artesunate intelligent prodrug liposomes based on mitochondrial targeting strategy
por: Gu, Liwei, et al.
Publicado: (2022) -
Indocyanine Green Liposomes for Diagnosis and Therapeutic Monitoring of Cerebral Malaria
por: Portnoy, Emma, et al.
Publicado: (2016) -
Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies
por: Tang, Zhongyuan, et al.
Publicado: (2019) -
Nonenzymatic Glucose Sensor Based on In Situ Reduction of Ni/NiO-Graphene Nanocomposite
por: Zhang, Xiaohui, et al.
Publicado: (2016) -
Glucocorticosteroids in Nano-Sterically Stabilized Liposomes Are Efficacious for Elimination of the Acute Symptoms of Experimental Cerebral Malaria
por: Waknine-Grinberg, Judith H., et al.
Publicado: (2013)